Telepharmacy follow-up using electronic patient-reported outcome measures in moderate-to-severe psoriasis
Telepharmacy-supported monitoring using validated ePROMs effectively captures longitudinal changes in HRQoL and symptom burden in patients with moderate-to-severe psoriasis. The achievement of predefined HRQoL targets supports their clinical relevance in real-world settings. These findings highlight the value of PROM-based, patient-centered digital follow-up and suggest that biologic-experienced patients and women may benefit from more tailored monitoring strategies.
Authors
- Salvador Herrera-Pérez
- Patricia Sanmartín-Fenollera (ORCID: https://orcid.org/0000-0002-5944-9182)
- Cristina C. Montes
- Piedad López Sánchez
- Aranzazu Pou Alonso
- Joaquín Borrás Blasco
- María Eugenia Escrivá Sancho
- Gabriel Mercadal-Orfila
- Emilio Monte-Boquet
- Jaime Notario Rosa
- Nuria Padullés-Zamora
- Olatz Ibarra-Barrueta
- María Angeles Bernabéu Martínez
Institutions
- Valencian International University (ES)
- Bellvitge University Hospital (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Hospital Universitari Sant Joan D'Alacant (ES)
- Hospital Universitario Fundación Alcorcón (ES)
- Hospital General de Tomelloso (ES)
- Hospital de Galdakao (ES)
- Hospital General Mateu Orfila (ES)
- Hospital de Sagunto (ES)
- Hospital Universitario de Fuenlabrada (ES)
- Universidad Europea de Madrid (ES)
Publication Details
- Journal
- Farmacia Hospitalaria
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1016/j.farma.2026.01.006
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00